Skip to main content

Advertisement

Table 2 Summary of study design and outcomes of included studies

From: Outcomes of dysvascular partial foot amputation and how these compare to transtibial amputation: a systematic review for the development of shared decision-making resources

Author Study design Outcomes
Wound healing Ipsilateral reamputation Quality of life Functional ability Mobility Proportionate mortality
Andrews et al. [77] Cohort—retrospective Healed at 3 and 12 months      
Boutoille et al. [38] Case control    Medical Outcome Study Short Form 36 (MOS SF-36)    
Brown et al. [17] Cohort—retrospective      Volpicelli ambulatory scale Mortality at 1, 3, 5 years
Czerniecki et al. [76] Cohort—prospective      Locomotor capabilities index 5  
Czerniecki et al. [34] Cohort—prospective      Locomotor capabilities index 5  
Dillingham and Pezzin [66] Cohort—retrospective   Reamputation at 1 year     Mortality at 1 year
Dillingham et al. [28] Cohort—retrospective       Mortality at 1 year
Evans et al. [18] Cohort—retrospective Healed at 1 year Reamputation at 1 year     Mortality at 2 years
Glaser et al. [65] Cohort—retrospective   Reamputation at 1 and 5 years     Mortality at 1, 3, 5 years
Griffin et al. [59] Cohort—retrospective       Mortality at 30 days and 1 year
Hambleton et al. [63] Case control       Mortality at 3 and 6 months and 1 and 5 years
Izumi et al. [27, 67] Cohort—retrospective   Reamputation at 1, 3, 5 years     Mortality at 10 months and 5 years
Jindeel and Narahara [68] Cohort—retrospective       Mortality at 1 and 5 years
Jones and Marshall [69] Cohort—retrospective       Mortality at 3 and 5 years
Kono and Muder [70] Cohort—retrospective   Reamputation at 6 months and 3 year     Mortality at 3 years
Kristensen et al. [61] Cohort—retrospective       Mortality at 30 days and 1 year
Lakstein et al. [64] Cohort—retrospective Healed at 3 weeks Reamputation at 4 weeks     
Marzen-Groller et al. [75] Cohorta     Modified functional independence measure   
Mayfield et al. [71] Cohort—retrospective       Mortality at 30 days and 5 years
Norvell et al. [33] Cohort—prospective      Locomotor capabilities index 5  
Peters et al. [35] Cohort—retrospective    Sickness impact profile Sickness impact profile   
Quigley et al. [36] Cross-sectional    Medical Outcome Study Short Form 36 (MOS SF-36 version 2)    
Sandnes et al. [72] Cohort—retrospective       Mortality at 30 days, 1 and 5 years
Sheahan et al. [73] Cohort—retrospective       Mortality at 30 days, 1 and 5 years
Stone et al. [74] Cohort—retrospective Healed at 3 months      Mortality at 60 days, 1, 3 and 5 years
Vamos et al. [60] Cohort—retrospective       Mortality at 30 days and 1 year
Winell et al. [62] Cross-sectional       Mortality at 2 years
Younger et al. [58] Case control   Reamputation at 1 year     
  1. aUnclear if this study is retrospective or prospective